Psoriasis comorbidities: complications and benefits of immunobiological treatment
Abstract During the last decade, different studies have converged to evidence the high prevalence of comorbidities in subjects with psoriasis. Although a causal relation has not been fully elucidated, genetic relation, inflammatory pathways and/or common environmental factors appear to be underlying...
Saved in:
Main Authors: | André Vicente Esteves de Carvalho (Author), Ricardo Romiti (Author), Cacilda da Silva Souza (Author), Renato Soriani Paschoal (Author), Laura de Mattos Milman (Author), Luana Pizarro Meneghello (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case series: psoriasis in solid organ transplant patients and immunobiological agents
by: Luana Pizarro Meneghello, et al.
Published: (2023) -
Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
by: Cynthia Cristina Ferreira Mota, et al.
Published: (2022) -
Infections in the era of immunobiologicals
by: Ricardo Romiti, et al.
Published: (2024) -
Evaluation of renal function in patients with psoriasis using immunobiologicals
by: Sarah Suyanne Carvalho Melgaco, et al.
Published: (2013) -
Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study
by: Renato Soriani Paschoal, et al.
Published: (2018)